These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8671250)

  • 1. Circulating immunoreactive and bioactive follicle stimulating hormone concentrations in anovulatory infertile women and during gonadotrophin induction of ovulation using a decremental dose regimen.
    van Dessel HJ; Schoot BC; Schipper I; Dahl KD; Fauser BC
    Hum Reprod; 1996 Mar; 11(3):478-85. PubMed ID: 8671250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
    Fauser BC; Donderwinkel P; Schoot DC
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
    J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency.
    Imani B; Eijkemans MJ; Faessen GH; Bouchard P; Giudice LC; Fauser BC
    Fertil Steril; 2002 Jan; 77(1):83-90. PubMed ID: 11779595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicle-stimulating hormone receptor polymorphisms in women with normogonadotropic anovulatory infertility.
    Laven JS; Mulders AG; Suryandari DA; Gromoll J; Nieschlag E; Fauser BC; Simoni M
    Fertil Steril; 2003 Oct; 80(4):986-92. PubMed ID: 14556822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome.
    Schipper I; Rommerts FF; Ten Hacken PM; Fauser BC
    J Clin Endocrinol Metab; 1997 May; 82(5):1325-31. PubMed ID: 9141511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.
    Laven JS; Mulders AG; Visser JA; Themmen AP; De Jong FH; Fauser BC
    J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
    Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid.
    Mason HD; Willis DS; Beard RW; Winston RM; Margara R; Franks S
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1355-60. PubMed ID: 7962330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum bioactive follicle-stimulating hormone during the human menstrual cycle and in hyper- and hypogonadotropic states: application of a sensitive granulosa cell aromatase bioassay.
    Jia XC; Kessel B; Yen SS; Tucker EM; Hsueh AJ
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1243-9. PubMed ID: 3084537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does metformin modify ovarian responsiveness during exogenous FSH ovulation induction in normogonadotrophic anovulation? A placebo-controlled double-blind assessment.
    van Santbrink EJ; Hohmann FP; Eijkemans MJ; Laven JS; Fauser BC
    Eur J Endocrinol; 2005 Apr; 152(4):611-7. PubMed ID: 15817918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women.
    Hedon B; Hugues JN; Emperaire JC; Chabaud JJ; Barbereau D; Boujenah A; Howles CM; Truong F
    Hum Reprod; 1998 Oct; 13(1O):2688-92. PubMed ID: 9804214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.
    Balen AH; Mulders AG; Fauser BC; Schoot BC; Renier MA; Devroey P; Struijs MJ; Mannaerts BM
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6297-304. PubMed ID: 15579793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropins.
    Lass A; Vassiliev A; Decosterd G; Warne D; Loumaye E
    Fertil Steril; 2002 Aug; 78(2):265-9. PubMed ID: 12137861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I; Hop WC; Fauser BC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect.
    O'Dea L; O'Brien F; Currie K; Hemsey G
    Curr Med Res Opin; 2008 Oct; 24(10):2785-93. PubMed ID: 18727841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.